Pluristem Life Systems Inc. Files Patent Application For Expanding Hematopoeitic Stem Cells (HSC) And Early Progenitor Cells From Cord Blood Non Selected Mono-Nuclear Cells (MNC)

HAIFA, Israel--(BUSINESS WIRE)--Feb. 8, 2006--Pluristem Life Systems, Inc. (OTC BB:PLRS: Company Identifies Simpler Approach for the Expansion of HSC Holding the Potential to Garner Significant Results and Allowing for a Substantially Larger Stem Cell Pool for Bone Marrow Transplantation.